NEW YORK (GenomeWeb News) – InforSense today said that it has "developed a long-term relationship" with Celera, under which the molecular diagnostics firm is using InforSense's Translational Research Solution in automating experimental data analysis and molecular annotation.

London-based InforSense said that it has provided Celera with a translation research platform that will support clinical data browsing, automated integration and analysis of enzyme-linked immunoassays, single nucleotide polymorphisms, and other experimental and public data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."